Get started
Author

Divya Singhal

OpenAlex ID: A5140311058
Mesenchymal stem cell-derived small extracellular vesicles in spinal cord injury: From molecular repair mechanisms to standardized translational development
2026 · Arwa Omar Al Khatib, Ulugbek Akhmedov, et al. · Journal of Neuroscience Methods · 1
MicroRNA–SIRT1 crosstalk in liver diseases: molecular regulation of metabolism, inflammation, and cell survival
2026 · Amr Ali Mohamed Abdelgawwad El-Sehrawy, Safa H. Radhie, et al. · Molecular Biology Reports · 1
Inflammation and cardiovascular risk in autoimmune diseases: Mechanisms, biomarkers, and clinical implications
2026 · Enas Daoud, Bobur Abduvoyitov, et al. · Clinica Chimica Acta · 1
Engineering smart polymeric lipid nanoparticles for breast cancer: The convergence of AI and medical personalization to enhance efficacy and safety
2026 · Usamah Sayed, Diyora Azamova, et al. · International Journal of Pharmaceutics
NRF2‐Regulated Ferroptosis in Breast Cancer: Mechanisms, Resistance, and Therapeutic Opportunities
2026 · Suleiman Ibrahim Mohammad, Asokan Vasudevan, et al. · Asia-Pacific Journal of Clinical Oncology
SLC7A11 in liver tissue homeostasis and disease: Cellular mechanisms linking ferroptosis, redox regulation, and hepatic cell survival
2026 · Jitendra Gupta, Musaab Hamid Farhan, et al. · Tissue and Cell
Sirtuin 1-microRNA regulatory networks in liver diseases: Mechanistic convergence, cellular senescence, and translational implications
2026 · Amr Ali Mohamed Abdelgawwad El-Sehrawy, Safa H. Radhie, et al. · Journal of Pharmacology and Experimental Therapeutics
Bioactivatable conjugated nanocarriers for synergistic mRNA-mediated cancer immunotherapy
2026 · Noman Nazir, Tushar B. Gajjar, et al. · Journal of Pharmacology and Experimental Therapeutics
Oncostatin M as a Multifunctional Regulator of Breast Cancer Progression: Current Insights and Future Therapeutic Avenues
2026 · Muslem Nuseir, Farrukh Ismatov, et al. · IUBMB Life
Gasdermin-mediated pyroptosis as a prognostic biomarker and therapeutic target in hepatocellular carcinoma
2026 · Tareq Nayef AlRamadneh, Inoyatillo Kholmurodov, et al. · Clinical Immunology
Circular Logic: Engineering Next‐Generation Circular RNA Therapeutics for Precision Oncology
2026 · Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Hamzeh J. Al‐Ameer, et al. · Biotechnology and Bioengineering
AEG-1/MTDH: A central regulator of tumor progression, metabolic adaptation, and therapeutic resistance in gliomas
2026 · Suleiman Ibrahim Mohammad, Asokan Vasudevan, et al. · Tissue and Cell
The innate regenerome: Harnessing mesenchymal niches and engineered cytotoxic killers for solid tumor immunotherapy
2026 · Amr Ali Mohamed Abdelgawwad El-Sehrawy, Usamah Sayed, et al. · Experimental Cell Research
Advances in monitoring and therapy from minimal residual disease to CAR-T cells in multiple myeloma and precursor disorders
2026 · Amr Ali Mohamed Abdelgawwad El-Sehrawy, Ghaleb Oriquat, et al. · Clinica Chimica Acta
Lymphatic extracellular vesicles and non-coding rnas in the melanoma sentinel lymph node pre-metastatic niche: Emerging lessons from aggressive skin cancers
2026 · Mustafa T Ardah, Umida Tashkenbaeva, et al. · Cancer Treatment and Research Communications
PDF
Acute respiratory viral inflammation and metastatic dormancy: direct evidence, mechanistic convergence, and research priorities
2026 · Ali M Atoom, Jasur Rizaev, et al. · Cancer Treatment and Research Communications
PDF
Oncolytic virotherapy at the tumor microenvironment–CAR Therapy interface: Mechanisms, clinical translation, and future directions
2026 · Ali M Atoom, Jasur Rizaev, et al. · Cancer Treatment and Research Communications
PDF
Viral exploitation of p300/CBP at the virus-cancer interface: Chromatin regulation, oncogenesis, immune evasion, and therapeutic targeting
2026 · Ali M Atoom, Jasur Rizaev, et al. · Cancer Treatment and Research Communications
PDF
Works count: 18
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type